Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Palo Alto, CA
SEC filing record 1 source field available
Fiscal year end
31 December
BridgeBio Pharma, Inc. has filed 812 SEC EDGAR filings since 19 Jun 2018

SEC filing history

Showing 801-812 of 812 matching filings.

Per page
25
Current page
33
DRS File 377-02513

DRS filing

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A File 001-38533

FORM 4/A SUBMISSION

Filing date
13 Dec 2018
Reporting date
10 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A File 001-38533

FORM 4/A SUBMISSION

Filing date
13 Dec 2018
Reporting date
06 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

SC 13D/A

Filing date
13 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38533

FORM 4 SUBMISSION

Filing date
12 Dec 2018
Reporting date
10 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

SC 13D/A

Filing date
11 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38533

FORM 4 SUBMISSION

Filing date
10 Dec 2018
Reporting date
06 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

SC 13D/A

Filing date
07 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38533

FORM 4 SUBMISSION

Filing date
06 Dec 2018
Reporting date
03 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D

SC 13D

Filing date
01 Aug 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38533

FORM 4 SUBMISSION

Filing date
26 Jun 2018
Reporting date
22 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 001-38533

FORM 3 SUBMISSION

Filing date
19 Jun 2018
Reporting date
19 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .